KATHERINE DIAZ: Open Payments
NPI 1255767455 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 17 payments from 11 companies in 2025. Trend: 2023 $384 · 2024 $246 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $161 |
| BeOne Medicines USA, Inc. | 1 | $131 |
| Daiichi Sankyo Inc. | 2 | $59 |
| SANOFI-AVENTIS U.S. LLC | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| ABBVIE INC. | 1 | $28 |
| BeiGene USA, Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $24 |
| PFIZER INC. | 1 | $20 |
| Incyte Corporation | 1 | $17 |
Products named: DARZALEX, BRUKINSA, ENHERTU, REZUROCK, DATROWAY, IMBRUVICA, SARCLISA, ELREXFIO.
Industry payments across FL — which companies pay providers there.
